Global Recombinant Hirudin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 117
Published Date: 16 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Recombinant Hirudin market size was valued at USD 1646.3 million in 2023 and is forecast to a readjusted size of USD 2357.5 million by 2030 with a CAGR of 5.3% during review period.
Hirudin is the most potent natural inhibitor of thrombin. Unlike antithrombin, hirudin binds to and inhibits only the activity of thrombin, with a specific activity on fibrinogen. Therefore, hirudin prevents or dissolves the formation of clots and thrombi (i.e., it has a thrombolytic activity), and has therapeutic value in blood coagulation disorders, in the treatment of skin hematomas and of superficial varicose veins, either as an injectable or a topical application cream. In some aspects, hirudin has advantages over more commonly used anticoagulants and thrombolytics, such as heparin, as it does not interfere with the biological activity of other serum proteins, and can also act on complexed thrombin.
It is difficult to extract large amounts of hirudin from natural sources, so a method for producing and purifying this protein using recombinant biotechnology has been developed. This has led to the development and marketing of a number of hirudin-based anticoagulant pharmaceutical products. Several other direct thrombin inhibitors are derived chemically from hirudin.
Recombinant Hirudin is derived from yeast and the polypeptide chain contains 65 amino acids and its Mw is 6979.5 Dalton which is identical to natural Hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. The Recombinant Hirudin is purified by proprietary chromatographic techniques.
The market drivers for Recombinant Hirudin are the increasing prevalence of thrombosis and tumor diseases, the growing demand for Recombinant Hirudin in the Asia Pacific and the Middle East & Africa regions, and the development of new products with improved features and performance.
The market constraints for Recombinant Hirudin are the high cost of Recombinant Hirudin compared to other anticoagulants, the limited availability and accessibility of Recombinant Hirudin in some regions, the need for regular monitoring and dosage adjustment of Recombinant Hirudin, and the risk of side effects and complications such as bleeding, allergic reactions, and antibody formation.
The market opportunities for Recombinant Hirudin are the increasing demand for Recombinant Hirudin among patients with heparin-induced thrombocytopenia (HIT), a condition where heparin causes low platelet count and increased risk of blood clots, the integration of Recombinant Hirudin with software and cloud-based platforms for better management and tracking of treatment outcomes, and the application of Recombinant Hirudin in new fields such as cosmetic surgery and dentistry.
The Global Info Research report includes an overview of the development of the Recombinant Hirudin industry chain, the market status of Thrombosis Disease (12000ATU/mg, 16000ATU/mg), Tumor Disease (12000ATU/mg, 16000ATU/mg), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant Hirudin.
Regionally, the report analyzes the Recombinant Hirudin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant Hirudin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Recombinant Hirudin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant Hirudin industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 12000ATU/mg, 16000ATU/mg).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant Hirudin market.
Regional Analysis: The report involves examining the Recombinant Hirudin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant Hirudin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Recombinant Hirudin:
Company Analysis: Report covers individual Recombinant Hirudin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant Hirudin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Thrombosis Disease, Tumor Disease).
Technology Analysis: Report covers specific technologies relevant to Recombinant Hirudin. It assesses the current state, advancements, and potential future developments in Recombinant Hirudin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant Hirudin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Recombinant Hirudin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
12000ATU/mg
16000ATU/mg
Market segment by Application
Thrombosis Disease
Tumor Disease
Major players covered
Abbott
The Medicines Company
Teva Pharmaceutical
Pfizer
Pentapharm
PrimeGene
Aniara Diagnostica
Bioassay Technology Laboratory
Novus Biologicals
Merck KGaA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Hirudin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Hirudin, with price, sales, revenue and global market share of Recombinant Hirudin from 2019 to 2024.
Chapter 3, the Recombinant Hirudin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Hirudin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Recombinant Hirudin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Hirudin.
Chapter 14 and 15, to describe Recombinant Hirudin sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Recombinant Hirudin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant Hirudin Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 12000ATU/mg
1.3.3 16000ATU/mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant Hirudin Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Thrombosis Disease
1.4.3 Tumor Disease
1.5 Global Recombinant Hirudin Market Size & Forecast
1.5.1 Global Recombinant Hirudin Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Recombinant Hirudin Sales Quantity (2019-2030)
1.5.3 Global Recombinant Hirudin Average Price (2019-2030)
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Recombinant Hirudin Product and Services
2.1.4 Abbott Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments/Updates
2.2 The Medicines Company
2.2.1 The Medicines Company Details
2.2.2 The Medicines Company Major Business
2.2.3 The Medicines Company Recombinant Hirudin Product and Services
2.2.4 The Medicines Company Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 The Medicines Company Recent Developments/Updates
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business
2.3.3 Teva Pharmaceutical Recombinant Hirudin Product and Services
2.3.4 Teva Pharmaceutical Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Teva Pharmaceutical Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Recombinant Hirudin Product and Services
2.4.4 Pfizer Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Pentapharm
2.5.1 Pentapharm Details
2.5.2 Pentapharm Major Business
2.5.3 Pentapharm Recombinant Hirudin Product and Services
2.5.4 Pentapharm Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pentapharm Recent Developments/Updates
2.6 PrimeGene
2.6.1 PrimeGene Details
2.6.2 PrimeGene Major Business
2.6.3 PrimeGene Recombinant Hirudin Product and Services
2.6.4 PrimeGene Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 PrimeGene Recent Developments/Updates
2.7 Aniara Diagnostica
2.7.1 Aniara Diagnostica Details
2.7.2 Aniara Diagnostica Major Business
2.7.3 Aniara Diagnostica Recombinant Hirudin Product and Services
2.7.4 Aniara Diagnostica Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Aniara Diagnostica Recent Developments/Updates
2.8 Bioassay Technology Laboratory
2.8.1 Bioassay Technology Laboratory Details
2.8.2 Bioassay Technology Laboratory Major Business
2.8.3 Bioassay Technology Laboratory Recombinant Hirudin Product and Services
2.8.4 Bioassay Technology Laboratory Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bioassay Technology Laboratory Recent Developments/Updates
2.9 Novus Biologicals
2.9.1 Novus Biologicals Details
2.9.2 Novus Biologicals Major Business
2.9.3 Novus Biologicals Recombinant Hirudin Product and Services
2.9.4 Novus Biologicals Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Novus Biologicals Recent Developments/Updates
2.10 Merck KGaA
2.10.1 Merck KGaA Details
2.10.2 Merck KGaA Major Business
2.10.3 Merck KGaA Recombinant Hirudin Product and Services
2.10.4 Merck KGaA Recombinant Hirudin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Merck KGaA Recent Developments/Updates
3.1 Global Recombinant Hirudin Sales Quantity by Manufacturer (2019-2024)
3.2 Global Recombinant Hirudin Revenue by Manufacturer (2019-2024)
3.3 Global Recombinant Hirudin Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Recombinant Hirudin by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Recombinant Hirudin Manufacturer Market Share in 2023
3.4.2 Top 6 Recombinant Hirudin Manufacturer Market Share in 2023
3.5 Recombinant Hirudin Market: Overall Company Footprint Analysis
3.5.1 Recombinant Hirudin Market: Region Footprint
3.5.2 Recombinant Hirudin Market: Company Product Type Footprint
3.5.3 Recombinant Hirudin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Recombinant Hirudin Market Size by Region
4.1.1 Global Recombinant Hirudin Sales Quantity by Region (2019-2030)
4.1.2 Global Recombinant Hirudin Consumption Value by Region (2019-2030)
4.1.3 Global Recombinant Hirudin Average Price by Region (2019-2030)
4.2 North America Recombinant Hirudin Consumption Value (2019-2030)
4.3 Europe Recombinant Hirudin Consumption Value (2019-2030)
4.4 Asia-Pacific Recombinant Hirudin Consumption Value (2019-2030)
4.5 South America Recombinant Hirudin Consumption Value (2019-2030)
4.6 Middle East and Africa Recombinant Hirudin Consumption Value (2019-2030)
5.1 Global Recombinant Hirudin Sales Quantity by Type (2019-2030)
5.2 Global Recombinant Hirudin Consumption Value by Type (2019-2030)
5.3 Global Recombinant Hirudin Average Price by Type (2019-2030)
6.1 Global Recombinant Hirudin Sales Quantity by Application (2019-2030)
6.2 Global Recombinant Hirudin Consumption Value by Application (2019-2030)
6.3 Global Recombinant Hirudin Average Price by Application (2019-2030)
7.1 North America Recombinant Hirudin Sales Quantity by Type (2019-2030)
7.2 North America Recombinant Hirudin Sales Quantity by Application (2019-2030)
7.3 North America Recombinant Hirudin Market Size by Country
7.3.1 North America Recombinant Hirudin Sales Quantity by Country (2019-2030)
7.3.2 North America Recombinant Hirudin Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Recombinant Hirudin Sales Quantity by Type (2019-2030)
8.2 Europe Recombinant Hirudin Sales Quantity by Application (2019-2030)
8.3 Europe Recombinant Hirudin Market Size by Country
8.3.1 Europe Recombinant Hirudin Sales Quantity by Country (2019-2030)
8.3.2 Europe Recombinant Hirudin Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Recombinant Hirudin Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Recombinant Hirudin Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Recombinant Hirudin Market Size by Region
9.3.1 Asia-Pacific Recombinant Hirudin Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Recombinant Hirudin Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Recombinant Hirudin Sales Quantity by Type (2019-2030)
10.2 South America Recombinant Hirudin Sales Quantity by Application (2019-2030)
10.3 South America Recombinant Hirudin Market Size by Country
10.3.1 South America Recombinant Hirudin Sales Quantity by Country (2019-2030)
10.3.2 South America Recombinant Hirudin Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Recombinant Hirudin Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Recombinant Hirudin Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Recombinant Hirudin Market Size by Country
11.3.1 Middle East & Africa Recombinant Hirudin Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Recombinant Hirudin Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Recombinant Hirudin Market Drivers
12.2 Recombinant Hirudin Market Restraints
12.3 Recombinant Hirudin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Recombinant Hirudin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Hirudin
13.3 Recombinant Hirudin Production Process
13.4 Recombinant Hirudin Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant Hirudin Typical Distributors
14.3 Recombinant Hirudin Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Recombinant Hirudin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Recombinant Hirudin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Recombinant Hirudin Product and Services
Table 6. Abbott Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Abbott Recent Developments/Updates
Table 8. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 9. The Medicines Company Major Business
Table 10. The Medicines Company Recombinant Hirudin Product and Services
Table 11. The Medicines Company Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. The Medicines Company Recent Developments/Updates
Table 13. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Major Business
Table 15. Teva Pharmaceutical Recombinant Hirudin Product and Services
Table 16. Teva Pharmaceutical Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Teva Pharmaceutical Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Recombinant Hirudin Product and Services
Table 21. Pfizer Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Pentapharm Basic Information, Manufacturing Base and Competitors
Table 24. Pentapharm Major Business
Table 25. Pentapharm Recombinant Hirudin Product and Services
Table 26. Pentapharm Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pentapharm Recent Developments/Updates
Table 28. PrimeGene Basic Information, Manufacturing Base and Competitors
Table 29. PrimeGene Major Business
Table 30. PrimeGene Recombinant Hirudin Product and Services
Table 31. PrimeGene Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. PrimeGene Recent Developments/Updates
Table 33. Aniara Diagnostica Basic Information, Manufacturing Base and Competitors
Table 34. Aniara Diagnostica Major Business
Table 35. Aniara Diagnostica Recombinant Hirudin Product and Services
Table 36. Aniara Diagnostica Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Aniara Diagnostica Recent Developments/Updates
Table 38. Bioassay Technology Laboratory Basic Information, Manufacturing Base and Competitors
Table 39. Bioassay Technology Laboratory Major Business
Table 40. Bioassay Technology Laboratory Recombinant Hirudin Product and Services
Table 41. Bioassay Technology Laboratory Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bioassay Technology Laboratory Recent Developments/Updates
Table 43. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 44. Novus Biologicals Major Business
Table 45. Novus Biologicals Recombinant Hirudin Product and Services
Table 46. Novus Biologicals Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Novus Biologicals Recent Developments/Updates
Table 48. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 49. Merck KGaA Major Business
Table 50. Merck KGaA Recombinant Hirudin Product and Services
Table 51. Merck KGaA Recombinant Hirudin Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Merck KGaA Recent Developments/Updates
Table 53. Global Recombinant Hirudin Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Recombinant Hirudin Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Recombinant Hirudin Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Recombinant Hirudin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Recombinant Hirudin Production Site of Key Manufacturer
Table 58. Recombinant Hirudin Market: Company Product Type Footprint
Table 59. Recombinant Hirudin Market: Company Product Application Footprint
Table 60. Recombinant Hirudin New Market Entrants and Barriers to Market Entry
Table 61. Recombinant Hirudin Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Recombinant Hirudin Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Recombinant Hirudin Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Recombinant Hirudin Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Recombinant Hirudin Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Recombinant Hirudin Average Price by Region (2019-2024) & (US$/Unit)
Table 67. Global Recombinant Hirudin Average Price by Region (2025-2030) & (US$/Unit)
Table 68. Global Recombinant Hirudin Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Recombinant Hirudin Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Recombinant Hirudin Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Recombinant Hirudin Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Recombinant Hirudin Average Price by Type (2019-2024) & (US$/Unit)
Table 73. Global Recombinant Hirudin Average Price by Type (2025-2030) & (US$/Unit)
Table 74. Global Recombinant Hirudin Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Recombinant Hirudin Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Recombinant Hirudin Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Recombinant Hirudin Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Recombinant Hirudin Average Price by Application (2019-2024) & (US$/Unit)
Table 79. Global Recombinant Hirudin Average Price by Application (2025-2030) & (US$/Unit)
Table 80. North America Recombinant Hirudin Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Recombinant Hirudin Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Recombinant Hirudin Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Recombinant Hirudin Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Recombinant Hirudin Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Recombinant Hirudin Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Recombinant Hirudin Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Recombinant Hirudin Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Recombinant Hirudin Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Recombinant Hirudin Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Recombinant Hirudin Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Recombinant Hirudin Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Recombinant Hirudin Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Recombinant Hirudin Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Recombinant Hirudin Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Recombinant Hirudin Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Recombinant Hirudin Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Recombinant Hirudin Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Recombinant Hirudin Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Recombinant Hirudin Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Recombinant Hirudin Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Recombinant Hirudin Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Recombinant Hirudin Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Recombinant Hirudin Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Recombinant Hirudin Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Recombinant Hirudin Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Recombinant Hirudin Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Recombinant Hirudin Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Recombinant Hirudin Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Recombinant Hirudin Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Recombinant Hirudin Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Recombinant Hirudin Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Recombinant Hirudin Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Recombinant Hirudin Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Recombinant Hirudin Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Recombinant Hirudin Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Recombinant Hirudin Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Recombinant Hirudin Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Recombinant Hirudin Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Recombinant Hirudin Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Recombinant Hirudin Raw Material
Table 121. Key Manufacturers of Recombinant Hirudin Raw Materials
Table 122. Recombinant Hirudin Typical Distributors
Table 123. Recombinant Hirudin Typical Customers
List of Figures
Figure 1. Recombinant Hirudin Picture
Figure 2. Global Recombinant Hirudin Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Recombinant Hirudin Consumption Value Market Share by Type in 2023
Figure 4. 12000ATU/mg Examples
Figure 5. 16000ATU/mg Examples
Figure 6. Global Recombinant Hirudin Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Recombinant Hirudin Consumption Value Market Share by Application in 2023
Figure 8. Thrombosis Disease Examples
Figure 9. Tumor Disease Examples
Figure 10. Global Recombinant Hirudin Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Recombinant Hirudin Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Recombinant Hirudin Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Recombinant Hirudin Average Price (2019-2030) & (US$/Unit)
Figure 14. Global Recombinant Hirudin Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Recombinant Hirudin Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Recombinant Hirudin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Recombinant Hirudin Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Recombinant Hirudin Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Recombinant Hirudin Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Recombinant Hirudin Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Recombinant Hirudin Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Recombinant Hirudin Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Recombinant Hirudin Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Recombinant Hirudin Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Recombinant Hirudin Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Recombinant Hirudin Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Recombinant Hirudin Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Recombinant Hirudin Average Price by Type (2019-2030) & (US$/Unit)
Figure 29. Global Recombinant Hirudin Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Recombinant Hirudin Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Recombinant Hirudin Average Price by Application (2019-2030) & (US$/Unit)
Figure 32. North America Recombinant Hirudin Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Recombinant Hirudin Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Recombinant Hirudin Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Recombinant Hirudin Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Recombinant Hirudin Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Recombinant Hirudin Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Recombinant Hirudin Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Recombinant Hirudin Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Recombinant Hirudin Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Recombinant Hirudin Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Recombinant Hirudin Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Recombinant Hirudin Consumption Value Market Share by Region (2019-2030)
Figure 52. China Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Recombinant Hirudin Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Recombinant Hirudin Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Recombinant Hirudin Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Recombinant Hirudin Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Recombinant Hirudin Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Recombinant Hirudin Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Recombinant Hirudin Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Recombinant Hirudin Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Recombinant Hirudin Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Recombinant Hirudin Market Drivers
Figure 73. Recombinant Hirudin Market Restraints
Figure 74. Recombinant Hirudin Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Recombinant Hirudin in 2023
Figure 77. Manufacturing Process Analysis of Recombinant Hirudin
Figure 78. Recombinant Hirudin Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Abbott The Medicines Company Teva Pharmaceutical Pfizer Pentapharm PrimeGene Aniara Diagnostica Bioassay Technology Laboratory Novus Biologicals Merck KGaA
Related Reports
11 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
